481
Views
8
CrossRef citations to date
0
Altmetric
Madness in method: controversies in guideline development

Quality, bias and service user experience in healthcare: 10 years of mental health guidelines at the UK National Collaborating Centre for Mental Health

, , &
Pages 342-351 | Received 20 Jul 2011, Accepted 20 Jul 2011, Published online: 25 Oct 2011

References

  • Brown, G.S., Lambert, M.J., Jones, E.R. & Minami, T. (2005). Identifying highly effective psychotherapists in a managed care environment. American Journal of Managed Care, 11, 513–520.
  • Eyding, D., Lelgemann, M., Grouven, U., Härter, M., Kromp, M., Kaiser, T. …Wieseler, B. (2010). Reboxetine for acute treatment of major depression: Systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ, 341, c4737.
  • Gaebel, W., Weinmann, S., Sartorius, N., Rutz, W, McIntyre, J.S. (2005). Schizophrenia practice guidelines: International survey and comparison. British Journal of Psychiatry, 187, 248–255.
  • Gaebel, W., Riesbeck M. & Wobrock T. (2011). Schizophrenia guidelines across the world: A selective review and comparison. International Review of Psychiatry, 23, 318–326.
  • Gerteis, M., Edgman-Levitan, S., Daley, J., Delbanco, T.L. (1993). Through the Patient's Eyes: Understanding and Promoting Patient-Centred Care. San Francisco: Jossey-Bass.
  • Gould, N. & Kendall, T. (2007). Developing the NICE/SCIE guidelines for dementia care: The challenges of enhancing the evidence base for social and health care. British Journal of Social Care, 37, 475–490.
  • Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., Leucht, S. (2006). Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. American Journal of Psychiatry, 163, 185–194.
  • Kendall, T. & McGoey, L. (2007). Truth, disclosure and the influence of industry on the development of NICE guidelines: An interview with Tim Kendall. BioSocieties, 2, 129–140.
  • Kendall, T., McGoey, L. & Jackson, E. (2009). If NICE was in the USA. Lancet, 374, 272–273.
  • Kendall, T. (2011). The rise and fall of the atypical antipsychotics. British Journal of Psychiatry, 119. In press.
  • Kirsch, I., Deacon, B., Heudo-Medina, T., Scoboria, A., Moore, T. & Johnson B. (2008). Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5, e45.
  • Kondro, W. & Sibbald, B. (2004). Drug company experts advised staff to withhold data about SSRI use in children. Canadian Medical Association Journal, 170, 783.
  • Laing, R.D. (1960). The Divided Self: A Study of Sanity and Madness. London: Tavistock Publications.
  • Lancet (2004). Depressing Research, Editorial. Lancet, 363, 1335.
  • Leucht, S., Corves, C., Arbter, D., Engel, R. R, Li, C. & Davis, J.M. (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet, 373, 31–44.
  • Lexchin, J., Bero, L.A., Djulbegovic, B. & Clark, O. (2003). Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ, 326, 1167–1170.
  • NCCMH (2003). Schizophrenia: Full National Clinical Guideline on Core Interventions in Primary and Secondary Care. Leicester & London: British Psychological Society and the Royal College of Psychiatrists.
  • NCCMH (2004). Self-Harm: the Short-Term Physical and Psychological Management and Secondary Prevention of Self-Harm in Primary and Secondary Care. Leicester & London: British Psychological Society and the Royal College of Psychiatrists.
  • NCCMH (2005a). Post-Traumatic Stress Disorder (PTSD): the Management of PTSD in Adults and Children in Primary and Secondary Care. Leicester & London: British Psychological Society and the Royal College of Psychiatrists.
  • NCCMH (2005b). Depression in Children and Young People: Identification and Management in Primary, Community and Secondary Care. Leicester & London: British Psychological Society and the Royal College of Psychiatrists.
  • NCCMH (2009). Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. Leicester & London: British Psychological Society and the Royal College of Psychiatrists.
  • NCCMH (2010a). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and SecondanJ Care. Updated edition. Leicester & London: British Psychological Society and the Royal College of Psychiatrists.
  • NCCMH (2010b). Depression: the Treatment and Management of Depression in Adults. Updated edition. Leicester & London: British Psychological Society and the Royal College of Psychiatrists.
  • NCCMH (2011). Generalised Anxiety Disorder and Panic Disorder (With or Without Agoraphobia) in Adults: Management in Primary, Secondary and Community Care. Leicester & London: British Psychological Society and the Royal College of Psychiatrists.
  • NICE (2002a). Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia. NICE Health Technology Appraisal Guidance Number 43. London: National Institute for Health and Clinical Excellence.
  • NICE (2002b). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. NICE clinical guideline 1. London: National Institute for Health and Clinical Excellence.
  • NICE (2004) Self-Harm: the Short-Term Physical and Psychological Management and Secondary Prevention of Self-Harm in Primary and Secondary Care. NICE clinical guideline 16. London: National Institute for Health and Clinical Excellence.
  • NICE (2005a). Post-Traumatic Stress Disorder (PTSD): the Management of PTSD in Adults and Children in Primary and Secondary Care. NICE clinical guideline 26. London: National Institute for Health and Clinical Excellence.
  • NICE (2005b). Depression in Children and Young People: Identification and Management in Primary, Community and Secondary Care. NICE clinical guideline 28. London: National Institute for Health and Clinical Excellence.
  • NICE (2008). Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. NICE clinical guideline 72. London: National Institute for Health and Clinical Excellence.
  • NICE (2009a). The Guidelines Manual. London: National Institute for Health and Clinical Excellence.
  • NICE (2009b). Depression: the Treatment and Management of Depression in Adults. NICE clinical guideline 90. London: National Institute for Health and Clinical Excellence.
  • NICE (2009c). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care. NICE clinical guideline 82. London: National Institute for Health and Clinical Excellence.
  • NICE (2011). Generalised Anxiety Disorder and Panic Disorder (With or Without Agoraphobia) in Adults: Management in Primary, Secondary and Community Care. NICE clinical guideline 113. London: National Institute for Health and Clinical Excellence.
  • Okiishi, J.C., Lambert, M.J., Eggett, D., Nielsen, L., Dayton, D.D. & Vermeersch, D.A. (2006). An analysis of therapist treatment effects: Toward providing feedback to individual therapists on their clients’ psychotherapy outcome. Journal of Clinical Psychology, 62, 1157–1172.
  • Perlis, R.H., Perlis, C.S., Wu, Y., Hwang, C., Joseph, M., Nierenberg, A.A. (2005). Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. American Journal of Psychiatry, 162, 1957–1960.
  • Pilling, S. & Price, K. (2006). Developing and implementing clinical guidelines: Lessons from the NICE schizophrenia guideline. Epidemiologia e Psichiatria Sociale, 15, 109–116.
  • Roth, A.D., Pilling, S. & Turner, J. (2010). Therapist training and supervision in clinical trials: Implications for clinical practice. Behavioural and Cognitive Psychotherapy, 38, 291–302
  • Singh, I., Kendall, T., Taylor, C., Hollis, C., Batty, M. & Mears, A. (2010). The experience of children and young people of ADHD and stimulant medication: a qualitative study for the NICE guideline. Journal of Child and Adolescent Mental Health, 15, 186–192.
  • Szasz, T.S. (1961). The Myth of Mental Illness: Foundations of a Theory of Personal Conduct (revised edition, 1974). New York: Harper & Row.
  • Turner, E.H., Matthews, A.M., Linardatos, E., Tell, R.A. & Rosenthal, R. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine, 358, 252–60.
  • Tyrer, P. & Kendall, T. (2009). The spurious advance of antipsychotic drug therapy. Lancet, 373, 4–5.
  • Whittington, C.J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A. & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet, 363, 1341–1345.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.